The global Pertussis Vaccine market is projected to grow from US$ 5384.9 million in 2024 to US$ 6619.4 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.5% during the forecast period.

Pertussis Vaccine Market

Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.

Global pertussis vaccine key players include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology etc. Global top 2 manufacturers hold a share about 90%. Europe is the largest market, with a share over 30%, followed by North America.

Report Covers:

This report presents an overview of global market for Pertussis Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Pertussis Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Pertussis Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pertussis Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pertussis Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pertussis Vaccine sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Pertussis Vaccine Market Report

Report Metric	Details
Report Name	Pertussis Vaccine Market
Accounted market size in 2024	US$ 5384.9 in million
Forecasted market size in 2030	US$ 6619.4 million
CAGR	3.5
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Whole-cell Vaccines Acellular Vaccines
Segment by Application	12 Months Below 12 Months Above
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology, Minhai Biotechnology, KM Biologics, Chengdu Institute of Biological Products
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Pertussis Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Pertussis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pertussis Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Pertussis Vaccine Market growing?

Ans: The Pertussis Vaccine Market witnessing a CAGR of 3.5 during the forecast period 2024-2030.

What is the Pertussis Vaccine Market size in 2030?

Ans: The Pertussis Vaccine Market size in 2030 will be US$ 6619.4 million.

What is the market share of major companies in Pertussis Vaccine Market?

Ans: Global top 2 manufacturers hold a share about 90%.

What is the Pertussis Vaccine Market share by region?

Ans: Europe is the largest market, with a share over 30%, followed by North America.

Who are the main players in the Pertussis Vaccine Market report?

Ans: The main players in the Pertussis Vaccine Market are Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology, Minhai Biotechnology, KM Biologics, Chengdu Institute of Biological Products

What are the Application segmentation covered in the Pertussis Vaccine Market report?

Ans: The Applications covered in the Pertussis Vaccine Market report are 12 Months Below, 12 Months Above

What are the Type segmentation covered in the Pertussis Vaccine Market report?

Ans: The Types covered in the Pertussis Vaccine Market report are Whole-cell Vaccines, Acellular Vaccines

1 Study Coverage

1.1 Pertussis Vaccine Product Introduction

1.2 Market by Type

1.2.1 Global Pertussis Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Whole-cell Vaccines

1.2.3 Acellular Vaccines

1.3 Market by Application

1.3.1 Global Pertussis Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 12 Months Below

1.3.3 12 Months Above

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Pertussis Vaccine Sales Estimates and Forecasts 2019-2030

2.2 Global Pertussis Vaccine Revenue by Region

2.2.1 Global Pertussis Vaccine Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Pertussis Vaccine Revenue by Region (2019-2024)

2.2.3 Global Pertussis Vaccine Revenue by Region (2025-2030)

2.2.4 Global Pertussis Vaccine Revenue Market Share by Region (2019-2030)

2.3 Global Pertussis Vaccine Sales Estimates and Forecasts 2019-2030

2.4 Global Pertussis Vaccine Sales by Region

2.4.1 Global Pertussis Vaccine Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Pertussis Vaccine Sales by Region (2019-2024)

2.4.3 Global Pertussis Vaccine Sales by Region (2025-2030)

2.4.4 Global Pertussis Vaccine Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Pertussis Vaccine Sales by Manufacturers

3.1.1 Global Pertussis Vaccine Sales by Manufacturers (2019-2024)

3.1.2 Global Pertussis Vaccine Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pertussis Vaccine in 2023

3.2 Global Pertussis Vaccine Revenue by Manufacturers

3.2.1 Global Pertussis Vaccine Revenue by Manufacturers (2019-2024)

3.2.2 Global Pertussis Vaccine Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Pertussis Vaccine Revenue in 2023

3.3 Global Key Players of Pertussis Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Pertussis Vaccine Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Pertussis Vaccine, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Pertussis Vaccine, Product Offered and Application

3.8 Global Key Manufacturers of Pertussis Vaccine, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Pertussis Vaccine Sales by Type

4.1.1 Global Pertussis Vaccine Historical Sales by Type (2019-2024)

4.1.2 Global Pertussis Vaccine Forecasted Sales by Type (2025-2030)

4.1.3 Global Pertussis Vaccine Sales Market Share by Type (2019-2030)

4.2 Global Pertussis Vaccine Revenue by Type

4.2.1 Global Pertussis Vaccine Historical Revenue by Type (2019-2024)

4.2.2 Global Pertussis Vaccine Forecasted Revenue by Type (2025-2030)

4.2.3 Global Pertussis Vaccine Revenue Market Share by Type (2019-2030)

4.3 Global Pertussis Vaccine Price by Type

4.3.1 Global Pertussis Vaccine Price by Type (2019-2024)

4.3.2 Global Pertussis Vaccine Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Pertussis Vaccine Sales by Application

5.1.1 Global Pertussis Vaccine Historical Sales by Application (2019-2024)

5.1.2 Global Pertussis Vaccine Forecasted Sales by Application (2025-2030)

5.1.3 Global Pertussis Vaccine Sales Market Share by Application (2019-2030)

5.2 Global Pertussis Vaccine Revenue by Application

5.2.1 Global Pertussis Vaccine Historical Revenue by Application (2019-2024)

5.2.2 Global Pertussis Vaccine Forecasted Revenue by Application (2025-2030)

5.2.3 Global Pertussis Vaccine Revenue Market Share by Application (2019-2030)

5.3 Global Pertussis Vaccine Price by Application

5.3.1 Global Pertussis Vaccine Price by Application (2019-2024)

5.3.2 Global Pertussis Vaccine Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Pertussis Vaccine Market Size by Type

6.1.1 US & Canada Pertussis Vaccine Sales by Type (2019-2030)

6.1.2 US & Canada Pertussis Vaccine Revenue by Type (2019-2030)

6.2 US & Canada Pertussis Vaccine Market Size by Application

6.2.1 US & Canada Pertussis Vaccine Sales by Application (2019-2030)

6.2.2 US & Canada Pertussis Vaccine Revenue by Application (2019-2030)

6.3 US & Canada Pertussis Vaccine Market Size by Country

6.3.1 US & Canada Pertussis Vaccine Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Pertussis Vaccine Sales by Country (2019-2030)

6.3.3 US & Canada Pertussis Vaccine Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Pertussis Vaccine Market Size by Type

7.1.1 Europe Pertussis Vaccine Sales by Type (2019-2030)

7.1.2 Europe Pertussis Vaccine Revenue by Type (2019-2030)

7.2 Europe Pertussis Vaccine Market Size by Application

7.2.1 Europe Pertussis Vaccine Sales by Application (2019-2030)

7.2.2 Europe Pertussis Vaccine Revenue by Application (2019-2030)

7.3 Europe Pertussis Vaccine Market Size by Country

7.3.1 Europe Pertussis Vaccine Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Pertussis Vaccine Sales by Country (2019-2030)

7.3.3 Europe Pertussis Vaccine Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Pertussis Vaccine Market Size

8.1.1 China Pertussis Vaccine Sales (2019-2030)

8.1.2 China Pertussis Vaccine Revenue (2019-2030)

8.2 China Pertussis Vaccine Market Size by Application

8.2.1 China Pertussis Vaccine Sales by Application (2019-2030)

8.2.2 China Pertussis Vaccine Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Pertussis Vaccine Market Size by Type

9.1.1 Asia Pertussis Vaccine Sales by Type (2019-2030)

9.1.2 Asia Pertussis Vaccine Revenue by Type (2019-2030)

9.2 Asia Pertussis Vaccine Market Size by Application

9.2.1 Asia Pertussis Vaccine Sales by Application (2019-2030)

9.2.2 Asia Pertussis Vaccine Revenue by Application (2019-2030)

9.3 Asia Pertussis Vaccine Sales by Region

9.3.1 Asia Pertussis Vaccine Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Pertussis Vaccine Revenue by Region (2019-2030)

9.3.3 Asia Pertussis Vaccine Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Pertussis Vaccine Market Size by Type

10.1.1 Middle East, Africa and Latin America Pertussis Vaccine Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Pertussis Vaccine Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Pertussis Vaccine Market Size by Application

10.2.1 Middle East, Africa and Latin America Pertussis Vaccine Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Pertussis Vaccine Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Pertussis Vaccine Sales by Country

10.3.1 Middle East, Africa and Latin America Pertussis Vaccine Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Pertussis Vaccine Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Pertussis Vaccine Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Sanofi Pasteur

11.1.1 Sanofi Pasteur Company Information

11.1.2 Sanofi Pasteur Overview

11.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Sanofi Pasteur Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Sanofi Pasteur Recent Developments

11.2 GSK

11.2.1 GSK Company Information

11.2.2 GSK Overview

11.2.3 GSK Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 GSK Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 GSK Recent Developments

11.3 Mitsubishi Tanabe Pharma

11.3.1 Mitsubishi Tanabe Pharma Company Information

11.3.2 Mitsubishi Tanabe Pharma Overview

11.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Mitsubishi Tanabe Pharma Recent Developments

11.4 Wuhan Institute of Biological Products

11.4.1 Wuhan Institute of Biological Products Company Information

11.4.2 Wuhan Institute of Biological Products Overview

11.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Wuhan Institute of Biological Products Recent Developments

11.5 Walvax Biotechnology

11.5.1 Walvax Biotechnology Company Information

11.5.2 Walvax Biotechnology Overview

11.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Walvax Biotechnology Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Walvax Biotechnology Recent Developments

11.6 Minhai Biotechnology

11.6.1 Minhai Biotechnology Company Information

11.6.2 Minhai Biotechnology Overview

11.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Minhai Biotechnology Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Minhai Biotechnology Recent Developments

11.7 KM Biologics

11.7.1 KM Biologics Company Information

11.7.2 KM Biologics Overview

11.7.3 KM Biologics Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 KM Biologics Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 KM Biologics Recent Developments

11.8 Chengdu Institute of Biological Products

11.8.1 Chengdu Institute of Biological Products Company Information

11.8.2 Chengdu Institute of Biological Products Overview

11.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Chengdu Institute of Biological Products Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Pertussis Vaccine Industry Chain Analysis

12.2 Pertussis Vaccine Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Pertussis Vaccine Production Mode & Process

12.4 Pertussis Vaccine Sales and Marketing

12.4.1 Pertussis Vaccine Sales Channels

12.4.2 Pertussis Vaccine Distributors

12.5 Pertussis Vaccine Customers

13 Market Dynamics

13.1 Pertussis Vaccine Industry Trends

13.2 Pertussis Vaccine Market Drivers

13.3 Pertussis Vaccine Market Challenges

13.4 Pertussis Vaccine Market Restraints

14 Key Findings in The Global Pertussis Vaccine Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Sanofi Pasteur

GSK

Wuhan Institute of Biological Products

Mitsubishi Tanabe Pharma

Walvax Biotechnology

Minhai Biotechnology

KM Biologics

Chengdu Institute of Biological Products

List of Tables

Table 1. Global Pertussis Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Whole-cell Vaccines

Table 3. Major Manufacturers of Acellular Vaccines

Table 4. Global Pertussis Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Pertussis Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Pertussis Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Pertussis Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 8. Global Pertussis Vaccine Revenue Market Share by Region (2019-2024)

Table 9. Global Pertussis Vaccine Revenue Market Share by Region (2025-2030)

Table 10. Global Pertussis Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 11. Global Pertussis Vaccine Sales by Region (2019-2024) & (M Doses)

Table 12. Global Pertussis Vaccine Sales by Region (2025-2030) & (M Doses)

Table 13. Global Pertussis Vaccine Sales Market Share by Region (2019-2024)

Table 14. Global Pertussis Vaccine Sales Market Share by Region (2025-2030)

Table 15. Global Pertussis Vaccine Sales by Manufacturers (2019-2024) & (M Doses)

Table 16. Global Pertussis Vaccine Sales Share by Manufacturers (2019-2024)

Table 17. Global Pertussis Vaccine Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 18. Global Pertussis Vaccine Revenue Share by Manufacturers (2019-2024)

Table 19. Global Key Players of Pertussis Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 20. Pertussis Vaccine Price by Manufacturers 2019-2024 (USD/Doses)

Table 21. Global Pertussis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Pertussis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pertussis Vaccine as of 2023)

Table 23. Global Key Manufacturers of Pertussis Vaccine, Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Pertussis Vaccine, Product Offered and Application

Table 25. Global Key Manufacturers of Pertussis Vaccine, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)

Table 28. Global Pertussis Vaccine Sales by Type (2025-2030) & (M Doses)

Table 29. Global Pertussis Vaccine Sales Share by Type (2019-2024)

Table 30. Global Pertussis Vaccine Sales Share by Type (2025-2030)

Table 31. Global Pertussis Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 32. Global Pertussis Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 33. Global Pertussis Vaccine Revenue Share by Type (2019-2024)

Table 34. Global Pertussis Vaccine Revenue Share by Type (2025-2030)

Table 35. Pertussis Vaccine Price by Type (2019-2024) & (USD/Doses)

Table 36. Global Pertussis Vaccine Price Forecast by Type (2025-2030) & (USD/Doses)

Table 37. Global Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)

Table 38. Global Pertussis Vaccine Sales by Application (2025-2030) & (M Doses)

Table 39. Global Pertussis Vaccine Sales Share by Application (2019-2024)

Table 40. Global Pertussis Vaccine Sales Share by Application (2025-2030)

Table 41. Global Pertussis Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 42. Global Pertussis Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 43. Global Pertussis Vaccine Revenue Share by Application (2019-2024)

Table 44. Global Pertussis Vaccine Revenue Share by Application (2025-2030)

Table 45. Pertussis Vaccine Price by Application (2019-2024) & (USD/Doses)

Table 46. Global Pertussis Vaccine Price Forecast by Application (2025-2030) & (USD/Doses)

Table 47. US & Canada Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)

Table 48. US & Canada Pertussis Vaccine Sales by Type (2025-2030) & (M Doses)

Table 49. US & Canada Pertussis Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 50. US & Canada Pertussis Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 51. US & Canada Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)

Table 52. US & Canada Pertussis Vaccine Sales by Application (2025-2030) & (M Doses)

Table 53. US & Canada Pertussis Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 54. US & Canada Pertussis Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 55. US & Canada Pertussis Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 56. US & Canada Pertussis Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 57. US & Canada Pertussis Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 58. US & Canada Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)

Table 59. US & Canada Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)

Table 60. Europe Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)

Table 61. Europe Pertussis Vaccine Sales by Type (2025-2030) & (M Doses)

Table 62. Europe Pertussis Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 63. Europe Pertussis Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 64. Europe Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)

Table 65. Europe Pertussis Vaccine Sales by Application (2025-2030) & (M Doses)

Table 66. Europe Pertussis Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 67. Europe Pertussis Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 68. Europe Pertussis Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. Europe Pertussis Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 70. Europe Pertussis Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 71. Europe Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)

Table 72. Europe Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)

Table 73. China Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)

Table 74. China Pertussis Vaccine Sales by Type (2025-2030) & (M Doses)

Table 75. China Pertussis Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 76. China Pertussis Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 77. China Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)

Table 78. China Pertussis Vaccine Sales by Application (2025-2030) & (M Doses)

Table 79. China Pertussis Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 80. China Pertussis Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 81. Asia Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)

Table 82. Asia Pertussis Vaccine Sales by Type (2025-2030) & (M Doses)

Table 83. Asia Pertussis Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 84. Asia Pertussis Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 85. Asia Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)

Table 86. Asia Pertussis Vaccine Sales by Application (2025-2030) & (M Doses)

Table 87. Asia Pertussis Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 88. Asia Pertussis Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia Pertussis Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 90. Asia Pertussis Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 91. Asia Pertussis Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 92. Asia Pertussis Vaccine Sales by Region (2019-2024) & (M Doses)

Table 93. Asia Pertussis Vaccine Sales by Region (2025-2030) & (M Doses)

Table 94. Middle East, Africa and Latin America Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)

Table 95. Middle East, Africa and Latin America Pertussis Vaccine Sales by Type (2025-2030) & (M Doses)

Table 96. Middle East, Africa and Latin America Pertussis Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 97. Middle East, Africa and Latin America Pertussis Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 98. Middle East, Africa and Latin America Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)

Table 99. Middle East, Africa and Latin America Pertussis Vaccine Sales by Application (2025-2030) & (M Doses)

Table 100. Middle East, Africa and Latin America Pertussis Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Pertussis Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Pertussis Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 103. Middle East, Africa and Latin America Pertussis Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Pertussis Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)

Table 106. Middle East, Africa and Latin America Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)

Table 107. Sanofi Pasteur Company Information

Table 108. Sanofi Pasteur Description and Major Businesses

Table 109. Sanofi Pasteur Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 110. Sanofi Pasteur Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Sanofi Pasteur Recent Developments

Table 112. GSK Company Information

Table 113. GSK Description and Major Businesses

Table 114. GSK Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 115. GSK Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. GSK Recent Developments

Table 117. Mitsubishi Tanabe Pharma Company Information

Table 118. Mitsubishi Tanabe Pharma Description and Major Businesses

Table 119. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 120. Mitsubishi Tanabe Pharma Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. Mitsubishi Tanabe Pharma Recent Developments

Table 122. Wuhan Institute of Biological Products Company Information

Table 123. Wuhan Institute of Biological Products Description and Major Businesses

Table 124. Wuhan Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 125. Wuhan Institute of Biological Products Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Wuhan Institute of Biological Products Recent Developments

Table 127. Walvax Biotechnology Company Information

Table 128. Walvax Biotechnology Description and Major Businesses

Table 129. Walvax Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 130. Walvax Biotechnology Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. Walvax Biotechnology Recent Developments

Table 132. Minhai Biotechnology Company Information

Table 133. Minhai Biotechnology Description and Major Businesses

Table 134. Minhai Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 135. Minhai Biotechnology Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. Minhai Biotechnology Recent Developments

Table 137. KM Biologics Company Information

Table 138. KM Biologics Description and Major Businesses

Table 139. KM Biologics Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 140. KM Biologics Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. KM Biologics Recent Developments

Table 142. Chengdu Institute of Biological Products Company Information

Table 143. Chengdu Institute of Biological Products Description and Major Businesses

Table 144. Chengdu Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 145. Chengdu Institute of Biological Products Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 146. Chengdu Institute of Biological Products Recent Developments

Table 147. Key Raw Materials Lists

Table 148. Raw Materials Key Suppliers Lists

Table 149. Pertussis Vaccine Distributors List

Table 150. Pertussis Vaccine Customers List

Table 151. Pertussis Vaccine Market Trends

Table 152. Pertussis Vaccine Market Drivers

Table 153. Pertussis Vaccine Market Challenges

Table 154. Pertussis Vaccine Market Restraints

Table 155. Research Programs/Design for This Report

Table 156. Key Data Information from Secondary Sources

Table 157. Key Data Information from Primary Sources

List of Figures

Figure 1. Pertussis Vaccine Product Picture

Figure 2. Global Pertussis Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Pertussis Vaccine Market Share by Type in 2023 & 2030

Figure 4. Whole-cell Vaccines Product Picture

Figure 5. Acellular Vaccines Product Picture

Figure 6. Global Pertussis Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Pertussis Vaccine Market Share by Application in 2023 & 2030

Figure 8. 12 Months Below

Figure 9. 12 Months Above

Figure 10. Pertussis Vaccine Report Years Considered

Figure 11. Global Pertussis Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Pertussis Vaccine Revenue 2019-2030 (US$ Million)

Figure 13. Global Pertussis Vaccine Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 14. Global Pertussis Vaccine Revenue Market Share by Region (2019-2030)

Figure 15. Global Pertussis Vaccine Sales 2019-2030 ((M Doses)

Figure 16. Global Pertussis Vaccine Sales Market Share by Region (2019-2030)

Figure 17. US & Canada Pertussis Vaccine Sales YoY (2019-2030) & (M Doses)

Figure 18. US & Canada Pertussis Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 19. Europe Pertussis Vaccine Sales YoY (2019-2030) & (M Doses)

Figure 20. Europe Pertussis Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 21. China Pertussis Vaccine Sales YoY (2019-2030) & (M Doses)

Figure 22. China Pertussis Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 23. Asia (excluding China) Pertussis Vaccine Sales YoY (2019-2030) & (M Doses)

Figure 24. Asia (excluding China) Pertussis Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Middle East, Africa and Latin America Pertussis Vaccine Sales YoY (2019-2030) & (M Doses)

Figure 26. Middle East, Africa and Latin America Pertussis Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 27. The Pertussis Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 28. The Top 5 and 10 Largest Manufacturers of Pertussis Vaccine in the World: Market Share by Pertussis Vaccine Revenue in 2023

Figure 29. Global Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 30. Global Pertussis Vaccine Sales Market Share by Type (2019-2030)

Figure 31. Global Pertussis Vaccine Revenue Market Share by Type (2019-2030)

Figure 32. Global Pertussis Vaccine Sales Market Share by Application (2019-2030)

Figure 33. Global Pertussis Vaccine Revenue Market Share by Application (2019-2030)

Figure 34. US & Canada Pertussis Vaccine Sales Market Share by Type (2019-2030)

Figure 35. US & Canada Pertussis Vaccine Revenue Market Share by Type (2019-2030)

Figure 36. US & Canada Pertussis Vaccine Sales Market Share by Application (2019-2030)

Figure 37. US & Canada Pertussis Vaccine Revenue Market Share by Application (2019-2030)

Figure 38. US & Canada Pertussis Vaccine Revenue Share by Country (2019-2030)

Figure 39. US & Canada Pertussis Vaccine Sales Share by Country (2019-2030)

Figure 40. U.S. Pertussis Vaccine Revenue (2019-2030) & (US$ Million)

Figure 41. Canada Pertussis Vaccine Revenue (2019-2030) & (US$ Million)

Figure 42. Europe Pertussis Vaccine Sales Market Share by Type (2019-2030)

Figure 43. Europe Pertussis Vaccine Revenue Market Share by Type (2019-2030)

Figure 44. Europe Pertussis Vaccine Sales Market Share by Application (2019-2030)

Figure 45. Europe Pertussis Vaccine Revenue Market Share by Application (2019-2030)

Figure 46. Europe Pertussis Vaccine Revenue Share by Country (2019-2030)

Figure 47. Europe Pertussis Vaccine Sales Share by Country (2019-2030)

Figure 48. Germany Pertussis Vaccine Revenue (2019-2030) & (US$ Million)

Figure 49. France Pertussis Vaccine Revenue (2019-2030) & (US$ Million)

Figure 50. U.K. Pertussis Vaccine Revenue (2019-2030) & (US$ Million)

Figure 51. Italy Pertussis Vaccine Revenue (2019-2030) & (US$ Million)

Figure 52. Russia Pertussis Vaccine Revenue (2019-2030) & (US$ Million)

Figure 53. China Pertussis Vaccine Sales Market Share by Type (2019-2030)

Figure 54. China Pertussis Vaccine Revenue Market Share by Type (2019-2030)

Figure 55. China Pertussis Vaccine Sales Market Share by Application (2019-2030)

Figure 56. China Pertussis Vaccine Revenue Market Share by Application (2019-2030)

Figure 57. Asia Pertussis Vaccine Sales Market Share by Type (2019-2030)

Figure 58. Asia Pertussis Vaccine Revenue Market Share by Type (2019-2030)

Figure 59. Asia Pertussis Vaccine Sales Market Share by Application (2019-2030)

Figure 60. Asia Pertussis Vaccine Revenue Market Share by Application (2019-2030)

Figure 61. Asia Pertussis Vaccine Revenue Share by Region (2019-2030)

Figure 62. Asia Pertussis Vaccine Sales Share by Region (2019-2030)

Figure 63. Japan Pertussis Vaccine Revenue (2019-2030) & (US$ Million)

Figure 64. South Korea Pertussis Vaccine Revenue (2019-2030) & (US$ Million)

Figure 65. China Taiwan Pertussis Vaccine Revenue (2019-2030) & (US$ Million)

Figure 66. Southeast Asia Pertussis Vaccine Revenue (2019-2030) & (US$ Million)

Figure 67. India Pertussis Vaccine Revenue (2019-2030) & (US$ Million)

Figure 68. Middle East, Africa and Latin America Pertussis Vaccine Sales Market Share by Type (2019-2030)

Figure 69. Middle East, Africa and Latin America Pertussis Vaccine Revenue Market Share by Type (2019-2030)

Figure 70. Middle East, Africa and Latin America Pertussis Vaccine Sales Market Share by Application (2019-2030)

Figure 71. Middle East, Africa and Latin America Pertussis Vaccine Revenue Market Share by Application (2019-2030)

Figure 72. Middle East, Africa and Latin America Pertussis Vaccine Revenue Share by Country (2019-2030)

Figure 73. Middle East, Africa and Latin America Pertussis Vaccine Sales Share by Country (2019-2030)

Figure 74. Brazil Pertussis Vaccine Revenue (2019-2030) & (US$ Million)

Figure 75. Mexico Pertussis Vaccine Revenue (2019-2030) & (US$ Million)

Figure 76. Turkey Pertussis Vaccine Revenue (2019-2030) & (US$ Million)

Figure 77. Israel Pertussis Vaccine Revenue (2019-2030) & (US$ Million)

Figure 78. GCC Countries Pertussis Vaccine Revenue (2019-2030) & (US$ Million)

Figure 79. Pertussis Vaccine Value Chain

Figure 80. Pertussis Vaccine Production Process

Figure 81. Channels of Distribution

Figure 82. Distributors Profiles

Figure 83. Bottom-up and Top-down Approaches for This Report

Figure 84. Data Triangulation

Figure 85. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions